Back to search

Article

A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulation

2024-02-01

Abstract excerpt

Incretin effect helps in regulating glucose homeostasis and maintaining glycaemic control within the human body. This effect is achieved by the two naturally occurring incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Such hormones released by specialized entero-endocrine cells of the gastrointestinal tract cause insulin augmentation after food consumption....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d112d07-d1d3-56e4-9191-c0390d751e5b
DOI
10.20944/preprints202402.0005.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulationDOI 10.20944/preprints202402.0005.v1
Recent advances in understanding the role of glucagon-like peptide 1Semantic proximity
The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive ReviewSemantic proximity
A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated ComorbiditiesSemantic proximity
Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.Semantic proximity
Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update.Semantic proximity
Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.Semantic proximity
The Cardiovascular Physiology of Glucagon-like Peptide-1 Receptor Agonists: From Macro-level Outcomes to Micro-level MechanismsSemantic proximity
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis by modulating mitochondrial functionSemantic proximity
Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort studySemantic proximity
Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patientsSemantic proximity
Generation and use of new tools for the characterisation of gut hormone receptorsSemantic proximity
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP ‐ 1R activationSemantic proximity
Select a neighboring publication to make it the new centre.